Stock Trading

  StockPlaysOnline - Hot Penny Stock Forums > StockPlaysOnline Member Forums > Large Cap Stocks

Reply
 
LinkBack Thread Tools Display Modes
  #1  
Old 09-15-2009, 07:36 AM
Member
 
Join Date: Aug 2009
Posts: 57
Default Lexicon Pharmaceuticals

Lexicon Pharmaceuticals obtained favorable results from recently completed Phase 1 studies of LX4211 and announced that it has initiated a Phase 2 clinical trial of the drug candidate in patients with type 2 diabetes mellitus. LX4211 is an orally-delivered, small molecule drug candidate that inhibits the sodium glucose transporter 2.
Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On



All times are GMT -4. The time now is 11:34 PM.